FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

 

 

Please select your country. This will keep you up to date with your country-specific information.

Arrive where effectiveness meets flexibility

Sentimag – Magtrace in magnetic lymph node localisation

Many treatments for early-stage cancer involve ‘sentinel lymph node biopsy’, or SLNB. This method, which identifies the lymph nodes with the highest potential for harbouring metastases, helps to determine the nodal stage of the cancer and make informed decisions for surgery and subsequent treatment.

Standard SLNB uses radioisotopes for sentinel node localisation. We offer an effective clinical solution that uses safe magnetic fields instead. This eliminates concerns related to the safety, workflow and availability associated with ionising radiation. Best practice SLNB is now possible everywhere, with no time restrictions.

Our system consists of the Sentimag® probe and the Magtrace® magnetic tracer. First, the tracer is injected into the interstitial tissue to provide a traceable signal. Next, using the Sentimag® probe, you locate the sentinel lymph nodes to determine how far the cancer has spread.

Magtrace® – an effective clinical solution

  • Perform best practice SLNB in any clinical setting
  • Eliminate issues with radioactive materials; reach equivalent clinical outcomes
  • As a surgeon, organise and manage the SLNB procedure to suit your needs
  • Inject the tracer at the best moment, up to seven days in advance
  • No evidence of anaphylaxis with interstitial tracer injection
  • Sentimag® and Magtrace® are CE-approved for SLN localisation


Endomag®, Sentimag®, Magseed® and Sienna+® are registered European Union trademarks of Endomagnetics Ltd · www.endomag.com
Magtrace® is a registered trademark of Endomagnetics Ltd in the United Kingdom · www.endomag.com

How can we help you?

Watch Penny’s story
Watch video
Watch Carmen’s story
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Company movie